Cystic Fibrosis – Overview
Cystic fibrosis is a lifelong, inherited condition that primarily affects the lungs and digestive system. Caused by mutations in the CFTR gene, this results in the production of thick, sticky mucus that clogs airways, traps bacteria, and causes repeated lung infections. Over time, these infections can damage lung tissue, leading to serious respiratory complications and reduced life expectancy.
This genetic disorder also impacts the pancreas, liver, intestines, and reproductive organs by obstructing ducts and disrupting normal function. The disease is autosomal recessive, meaning a child must inherit two faulty CFTR genes (one from each parent) to develop the condition. Those who inherit only one faulty gene are carriers but typically do not show symptoms.
The severity of cystic fibrosis varies between individuals, even among siblings. Some people live with relatively mild symptoms, while others experience life-threatening complications. With advances in treatment, particularly the development of CFTR modulator therapies, the outlook for people with this condition has improved significantly in recent years.
Cystic Fibrosis
Symptoms usually begin in infancy or early childhood, but adults can also be diagnosed later in life. Persistent coughing, frequent lung infections, poor weight gain, and digestive issues are common signs. Early diagnosis and continuous management are critical to slowing disease progression and maintaining quality of life.
In summary, cystic fibrosis is a complex genetic disorder that requires lifelong care. Though it poses significant challenges, early intervention, comprehensive treatment, and ongoing support can help individuals with this condition lead active and fulfilling lives.
[Next: Causes of Cystic Fibrosis →]
